A new study offers new hope for patients of cervical cancer.
Vaccine for HPV (human papillomavirus), which causes cervical cancer, has been observed to be reducing “infections, genital and anal warts, and precancerous lesions in young women and girls in more than a dozen wealthy countries” as per a report in The Lancet.
Experts hope this will eventually cause a huge drop in the cases of cervical cancer worldwide.
The analysis included data from a dozen of other studies of at least 66 million females and males below the age of 30 who were living in 14 of the developed, wealthy countries of the world. The HPV vaccines in these 14 countries were introduced 12 years back i.e. in 2007.


